Literature DB >> 20666681

Juxtafoveal choroidal neovascularization secondary to persistent placoid maculopathy treated with intravitreal bevacizumab.

Maurizio Battaglia Parodi1, Pierluigi Iacono, Francesco Bandello.   

Abstract

PURPOSE: To describe a case of persistent placoid maculopathy (PPM) associated with juxtafoveal choroidal neovascularization (CNV) treated with intravitreal bevacizumab injection (IVBI).
DESIGN: Interventional case report.
METHODS: A 60-year-old patient referred for sudden vision loss was diagnosed with PPM complicated by a disciform scar in the right eye and juxtafoveal CNV in the left eye, undergoing 2 IVBIs.
RESULTS: Best-corrected visual acuity passed from 20/32 to 20/20 after 2 IVBIs, with complete resolution of intraretinal and subretinal fluid and disappearance of fluorescein leakage.
CONCLUSIONS: IVBI is a promising treatment option for juxtafoveal CNV secondary to PPM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20666681     DOI: 10.3109/09273948.2010.483316

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  The identification of activity of choroidal neovascularization complicating angioid streaks.

Authors:  Alessandro Marchese; Chiara Giuffrè; Maria Vittoria Cicinelli; Alessandro Arrigo; Francesco Bandello; Maurizio Battaglia Parodi
Journal:  Eye (Lond)       Date:  2021-05-10       Impact factor: 4.456

2.  Comparison of choroidal neovascularization secondary to white dot syndromes and age-related macular degeneration by using optical coherence tomography angiography.

Authors:  Jay C Wang; Kenneth M McKay; Arjun B Sood; Inês Laíns; Lucia Sobrin; John B Miller
Journal:  Clin Ophthalmol       Date:  2018-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.